PARP inhibitors in prostate cancer: A promise delivered
PARP inhibitors in prostate cancer: A promise delivered
SIOG 2020 Annual Meeting global message and continuity with SIOG 2021
Targeting a KRAS neoantigen peptide vaccine to DNGR-1 dendritic cells
OncoAlert and ecancer weekly roundup for November 15 - 21, 2020
Updates in geriatric oncology from SIOG 2020
Clinical genomic testing in prostate cancer
PARP inhibitors for prostate cancer - Nurse's view
Predictors of efficacy in patients with HR positive/HER2 negative ABC: Subgroup analyses of PALOMA-3
Using circulating tumour DNA dynamics to predict outcomes in advanced cancers
Using AI to examine muscle mass in brain tumour patients
Estimating risk of death from COVID in cancer patients
OncoAlert and ecancer weekly roundup for November 8 - 14, 2020